Pacific Northwest National Laboratory, Richland, WA 99352, USA; School of Molecular Biosciences, Washington State University, Pullman, WA 99164, USA.
Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Arch Oral Biol. 2018 Sep;93:187-194. doi: 10.1016/j.archoralbio.2018.06.001. Epub 2018 Jun 6.
The aim of this study was to identify major matrix metalloproteinase-20 (MMP20) proteolytic processing products of amelogenin over time and determine if the tyrosine-rich amelogenin peptide (TRAP) was a substrate of MMP20.
RecombinantN-labeled murine amelogenin and C,N-labeled TRAP were incubated with MMP20 under conditions where amelogenin self-assembles into nanospheres. Digestion products were fractionated by reverse-phase high-performance liquid chromatography at various time points. Product identification took advantage of the intrinsic disorder property of amelogenin that results in little change to its fingerprint H-N heteronuclear single-quantum coherence nuclear magnetic resonance spectrum in 2% acetic acid upon removing parts of the protein, allowing cleavage site identification by observing which amide cross peaks disappear.
The primary product in five out of the six major reverse-phase high-performance liquid chromatography bands generated after a 24 h incubation of murine amelogenin with MMP20 were: S55-L163, P2-L147, P2-E162, P2-A167, and P2-R176. After 72 h these products were replaced with five major reverse-phase high-performance liquid chromatography bands containing: L46-A170, P2-S152, P2-F151, P2-W45, and short N-terminal peptides. TRAP was completely digested by MMP20 into multiple small peptides with the initial primary site of cleavage between S16 and Y17.
Identification of the major MMP20 proteolytic products of amelogenin confirm a dynamic process, with sites towards the C-terminus more rapidly attacked than sites near the N-terminus. This observation is consistent with nanosphere models where the C-terminus is exposed and the N-terminus more protected. One previously reported end-product of the MMP20 proteolytic processing of amelogenin, TRAP, is shown to be an in vitro substrate for MMP20.
本研究旨在确定釉原蛋白(amelogenin)在时间推移过程中主要的基质金属蛋白酶-20(matrix metalloproteinase-20,MMP20)蛋白水解产物,并确定富含酪氨酸的釉原蛋白肽(tyrosine-rich amelogenin peptide,TRAP)是否为 MMP20 的底物。
在釉原蛋白自组装成纳米球的条件下,用 MMP20 孵育重组 N-标记的鼠釉原蛋白和 C,N-标记的 TRAP。在不同时间点,通过反相高效液相色谱法对消化产物进行分级。利用釉原蛋白的固有无序特性,在去除部分蛋白质后,其指纹 H-N 异核单量子相干核磁共振(nuclear magnetic resonance,NMR)谱在 2%乙酸中几乎没有变化,通过观察酰胺交叉峰的消失来确定切割位点,从而实现产物鉴定。
在 MMP20 孵育鼠釉原蛋白 24 小时后,在 6 个主要反相高效液相色谱带中的 5 个带中生成了主要产物:S55-L163、P2-L147、P2-E162、P2-A167 和 P2-R176。72 小时后,这些产物被含有 5 个主要反相高效液相色谱带的产物取代,其中包含:L46-A170、P2-S152、P2-F151、P2-W45 和短 N 端肽。TRAP 被 MMP20 完全水解成多个小肽,初始切割位点在 S16 和 Y17 之间。
釉原蛋白主要 MMP20 蛋白水解产物的鉴定证实了一个动态过程,C 端的位点比靠近 N 端的位点更快受到攻击。这一观察结果与纳米球模型一致,在该模型中,C 端暴露而 N 端受到保护。MMP20 对釉原蛋白的蛋白水解处理的一个先前报道的终产物,TRAP,被证明是 MMP20 的体外底物。